meta-analysis | Q815382 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1008763677 |
P356 | DOI | 10.1186/S13000-015-0380-3 |
P932 | PMC publication ID | 4537540 |
P698 | PubMed publication ID | 26276145 |
P5875 | ResearchGate publication ID | 281813580 |
P2093 | author name string | Sheng-wen Wu | |
Cong-chao Ma | |||
Wen-hui Li | |||
P2860 | cites work | Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. | Q27824766 |
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints | Q27860640 | ||
Measuring inconsistency in meta-analyses | Q27860655 | ||
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene | Q27860693 | ||
Practical methods for incorporating summary time-to-event data into meta-analysis | Q28131754 | ||
Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene | Q28286890 | ||
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer | Q29547699 | ||
ERBB receptors and cancer: the complexity of targeted inhibitors | Q29619520 | ||
Is overexpression of HER-2 a predictor of prognosis in colorectal cancer? | Q30856729 | ||
Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas | Q33943812 | ||
HER-2 overexpression and survival in colorectal cancer: a meta-analysis | Q33979049 | ||
Adjuvant trastuzumab in HER2-positive breast cancer | Q35710898 | ||
Increasing incidence of colorectal cancer in Asia: implications for screening | Q36300753 | ||
c-erbB-2 is not a major factor in the development of colorectal cancer | Q36644043 | ||
The expression of multiple proteins as prognostic factors in colorectal cancer: cathepsin D, p53, COX-2, epidermal growth factor receptor, C-erbB-2, and Ki-67 | Q37564008 | ||
HER-2/neu overexpression is an independent prognostic factor in colorectal cancer. | Q40291966 | ||
Prognostic significance of p53 and c-erbB-2 immunohistochemical evaluation in colorectal adenocarcinoma | Q40981286 | ||
erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells | Q42807469 | ||
ErbB family immunohistochemical expression in colorectal cancer patients with higher risk of recurrence after radical surgery. | Q47950050 | ||
Clinical role of HER-2/neu expression in colorectal cancer. | Q51046708 | ||
Frequency of HER-2 positivity in rectal cancer and prognosis. | Q51283402 | ||
Prognostic significance of c-erbB-2 and vascular endothelial growth factor in colorectal liver metastases. | Q51789617 | ||
Expression analysis of heat shock protein 90 (HSP90) and Her2 in colon carcinoma. | Q53091400 | ||
Clinico-Pathological and Prognostic Significance of p53, Bcl-2 and Her-2/neu Protein Markers in Colorectal Cancer Using Tissue Microarray. | Q53317073 | ||
Assessment of staging, prognosis and mortality of colorectal cancer by tumor markers: receptor erbB-2 and cadherins. | Q53648066 | ||
Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer. | Q54280357 | ||
The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity | Q70141373 | ||
c-erbB-2 protein expression and clinicopathologic features in colorectal cancer | Q73081149 | ||
The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer | Q73212054 | ||
The prognostic value of invariant chain (Ii) and Her-2/neu expression in curatively resected colorectal cancer | Q74325369 | ||
Immunohistochemical study of c-erbB-2 protein in colorectal cancer and the correlation with patient survival | Q77432075 | ||
Over-expression of Her-2 in colorectal cancer tissue, but not in serum, constitutes an independent worse prognostic factor | Q86876904 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | colorectal cancer | Q188874 |
overexpression | Q61643320 | ||
P304 | page(s) | 144 | |
P577 | publication date | 2015-08-16 | |
P1433 | published in | Diagnostic Pathology | Q18397261 |
P1476 | title | Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis | |
P478 | volume | 10 |
Q97525750 | Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance |
Q57183898 | Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status |
Q28078111 | HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists |
Q61816598 | Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib |